D-dimer assays – pitfalls of analytical comparisons
نویسنده
چکیده
When a new D-dimer method is evaluated it is typically compared to an established D-dimer method. Usually both an analytical and a clinical comparison are made. The range of clinical specificities between D-dimer assays is wide (from 30 % to above 90 %), which is due to heterogeneity between D-dimer molecules and difference between antibody specificity towards them, especially concerning the preference for high or low molecular weight degradation products and for crosslinked over non-crosslinked degradation products. Discrepancies between studies of the same assays are predominantly related to differences between study populations. Many conditions may give elevated D-dimer concentration without the presence of venous thromboembolism (VTE), which will influence performance. The mixture of these conditions is most often not known or fully disclosed in published studies. Thus the discrepancies between methods and studies mean that you cannot directly compare two analytical results obtained with different methods. We have experienced that D-dimer assay correlation studies are too often presented and interpreted in a misleading way in literature. A hypothetical comparison of 3 assays is presented. A comparator assay with sensitivity 100 % and specificity 45 % is used to compare 2 other assays, with sensitivity 95 % and specificity 45 %, and with sensitivity 95 % and specificity 60 %, respectively. The examples show that the assay that has the better clinical performance has a poorer correlation, a lower overall agreement and a higher negative calculated bias at the cut-off vs. the comparator assay. Thus it must be emphasized that D-dimer assay comparisons should be based on clinical performance where the same samples are measured with all the methods compared. Analytical comparisons should be discouraged, as they do not give any useful information about the potential clinical usability of the assay. Page 1 Article downloaded from acutecaretesting.org Suzanne Ekelund and Maja Eliasen: D-dimer assays – pitfalls of analytical comparisons Maja Eliasen, MSc Technical Product Manager Radiometer Medical ApS Åkandevej 21 2700 Brønshøj, Denmark Phone: +45 38272412 E-mail: [email protected] Suzanne Ekelund, MSc Principal Specialist Clinical Biochemist Radiometer Medical ApS Åkandevej 21 2700 Brønshøj , Denmark Phone: +45 3827 3116 E-mail: [email protected]
منابع مشابه
The Effect of Preanalytical, Analytical, and Postanalytical Variables on D-dimer Measurement
D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of activation of coagulation and fibrinolysis, and it is routinely used for ruling out venous thromboembolism (VTE). D-dimer is increasingly used to assess the risk of VTE recurrence and to help define the uoptimal duration of anticoa...
متن کاملEvaluation of the Innovance D-DIMER analytical performance.
BACKGROUND Widespread use of D-dimer in recent years has led to the development of a number of new fully automated quantitative D-dimer assays. METHODS We evaluated the analytical performance of the particle-enhanced immunoturbidimetric assay Innovance D-DIMER (Siemens Medical Solutions) on the Behring Coagulation System (BCS) analyzer. RESULTS Within-run coefficients of variation (CVs) for...
متن کاملAnalytical and clinical validation of a new point-of-care testing system for determination of D-Dimer in human blood.
D-Dimer testing is used for exclusion of deep venous thrombosis (DVT). AQT90 FLEX D-Dimer (AQT D-Dimer) is a novel time-resolved fluorescence based point-of-care test for quantification of D-Dimer in whole blood or plasma. Presently we have determined the analytical and clinical performance of AQT D-Dimer and compared it with four routine D-Dimer assays. The within-run CV of AQT D-Dimer was 3.8...
متن کاملDoes the Platelet Index Have a Guiding Role in the Association of Cancer and Pulmonary Thromboembolism?
Introduction: The diagnostic value of the D-dimer test varies with variable platelet numbers and functions in patients suffering from cancer and concomitant pulmonary thromboembolism (PTE). This requires easy and reliable evaluation tests. In this study, we aimed to investigate the hypothesis that platelet functions may be more guiding in the prediction and diagnosis of PTE rather than the numb...
متن کاملReview: several factors are associated with the performance of D-dimer assays for detecting deep venous thrombosis.
and commentary also appear in ACP Journal Club. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . For correspondence: Dr S W Heim, University of Virginia Health System, Charlottesville, VA, USA. [email protected] Source of funding: US Department of Health and Human Services. Factors associated with the performance (diagnos...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016